User profiles for Karina D. Sørensen
Karina Dalsgaard SorensenAarhus University, Denmark Verified email at clin.au.dk Cited by 8722 |
[HTML][HTML] A dual program for translation regulation in cellular proliferation and differentiation
…, LL Christensen, M Borre, KD Sørensen… - Cell, 2014 - cell.com
A dichotomous choice for metazoan cells is between proliferation and differentiation. Measuring
tRNA pools in various cell types, we found two distinct subsets, one that is induced in …
tRNA pools in various cell types, we found two distinct subsets, one that is induced in …
[PDF][PDF] An optimized shotgun strategy for the rapid generation of comprehensive human proteomes
…, SC Larsen, C Haldrup, JB Bramsen, KD Sørensen… - Cell systems, 2017 - cell.com
This study investigates the challenge of comprehensively cataloging the complete human
proteome from a single-cell type using mass spectrometry (MS)-based shotgun proteomics. …
proteome from a single-cell type using mass spectrometry (MS)-based shotgun proteomics. …
[HTML][HTML] Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis
K Thorsen, KD Sørensen, AS Brems-Eskildsen… - Molecular & Cellular …, 2008 - ASBMB
Alternative splicing enhances proteome diversity and modulates cancer-associated proteins.
To identify tissue- and tumor-specific alternative splicing, we used the GeneChip Human …
To identify tissue- and tumor-specific alternative splicing, we used the GeneChip Human …
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas
…, KD Sørensen… - … journal of cancer, 2011 - Wiley Online Library
In our study, whole‐genome methylation arrays were applied to identify novel genes with
tumor specific DNA methylation of promoter CpG islands in pre‐malignant and malignant …
tumor specific DNA methylation of promoter CpG islands in pre‐malignant and malignant …
DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer
…, M Borre, S Høyer, TF Ørntoft, KD Sørensen - Journal of Clinical …, 2013 - ascopubs.org
Purpose Diagnostic and prognostic tools for prostate cancer (PC) are suboptimal, causing
overtreatment of indolent PC and risk of delayed treatment of aggressive PC. Here, we identify …
overtreatment of indolent PC and risk of delayed treatment of aggressive PC. Here, we identify …
The potential of microRNAs as prostate cancer biomarkers
Context Short noncoding RNAs known as microRNAs (miRNAs) control protein expression
through the degradation of RNA or the inhibition of protein translation. The miRNAs influence …
through the degradation of RNA or the inhibition of protein translation. The miRNAs influence …
[HTML][HTML] Diagnostic and prognostic microRNA biomarkers for prostate cancer in cell-free urine
…, S Høyer, M Borre, TF Ørntoft, KD Sørensen - European Urology …, 2018 - Elsevier
Background Widespread use of prostate-specific antigen (PSA) testing for prostate cancer (PC)
detection has led to extensive overdiagnosis and overtreatment. Urine-based microRNA (…
detection has led to extensive overdiagnosis and overtreatment. Urine-based microRNA (…
Profiling of circulating microRNAs for prostate cancer biomarker discovery
…, M Borre, S Høyer, TF Orntoft, KD Sorensen - Drug delivery and …, 2014 - Springer
Prostate cancer (PC) is the most frequent cancer in men in the Western world. Currently,
serum prostate-specific antigen levels and digital rectal examinations are used to indicate the …
serum prostate-specific antigen levels and digital rectal examinations are used to indicate the …
68Ga-PSMA PET/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer
…, BP Ulhøi, J Fredsøe, KD Sørensen… - Journal of Nuclear …, 2021 - Soc Nuclear Med
With the largest high-risk prostate cancer (PCa) cohort to date undergoing 68 Ga-prostate-specific
membrane antigen (PSMA) PET/CT primary staging, we aimed to, first, characterize …
membrane antigen (PSMA) PET/CT primary staging, we aimed to, first, characterize …
Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
…, S Høyer, M Borre, TF Ørntoft, KD Sørensen - Clinical Cancer …, 2014 - AACR
Purpose: Available tools for prostate cancer diagnosis and prognosis are suboptimal and
novel biomarkers are urgently needed. Here, we investigated the regulation and biomarker …
novel biomarkers are urgently needed. Here, we investigated the regulation and biomarker …